Chul Kim
@chulkimmd
Thoracic Medical Oncologist at Georgetown University | Lung Cancer & Thymic Epithelial Tumors | Father/husband/immigrant | #SoMeEditor @ClinicalLung | #LCSM
ID: 830044361979224064
10-02-2017 13:22:52
2,2K Tweet
2,2K Followers
753 Following
Stellar presentation on ADCs targeting TROP-2, MET, and CEACAM by our Dr. Joshua Reuss MET and TROP-2 ADCs have been actively investigated and may potentially become part of SOC. Qs: biomarkers, sequencing approaches if multiple ADCs available, improving therapeutic index
